Skip to main content
Premium Trial:

Request an Annual Quote

Power3 Shareholders File Motion to Dismiss Insider Trading Lawsuit


Power3 Medical Products shareholders Richard Kraniak and Roger Kazanowski filed a motion last week to dismiss a lawsuit brought by the company against them alleging insider trading.

According to the memorandum submitted by the defendants, Power3's complaint failed to "allege sufficient facts to state a claim for liability" under the Securities Exchange Act and the Securities Act, and failed to "plead with specificity necessary elements for these claims."

Power3 filed the suit on April 14, claiming that Kraniak and Kazanowski illegally profited from insider information regarding Power3's acquisition of stem cell firm StemTronix. On May 28 the defendants filed a motion in United States District Court for the Southern District of Texas to have the charges dismissed. As of that date, neither defendant had been served.

According to the memorandum, Power3's complaint provided no specific allegations as to when Kraniak and Kazanowski "purportedly executed any purchase or sale of Power3 securities," "the identity of the purchaser or seller, or the alleged trading profits or losses by anyone," "the nature of the purported 'inside information,'" "the materiality of the information as of the time of the alleged purchase or sale," "the intent of the issuer to impose confidentiality upon the information," or how the defendants "purportedly came into contact with the information."

Both Richard Martini, attorney for Power3, and Thomas Taylor, the lawyer filing the motion on behalf of the defendants, were unavailable for comment.

Last month, Peter Sarkesian, a lawyer for Kraniak and Kazanowski, told ProteoMonitor that if the matter was not resolved, his clients intended to file a counterclaim against the company and its officers "for breach of contract, misrepresentation, very probably defamation, breach of their fiduciary duty to the company and its shareholders, and in all probability there will be security law violations that we will allege, as well, on the part of the officers" (PM 5/7/2010).

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.